Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Toxins01:36

Types of Toxins

2.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
2.7K
Drug Regulation01:25

Drug Regulation

2.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.2K
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

38
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
38
Bioremediation00:46

Bioremediation

21.5K
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
21.5K
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

656
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
656
Environmental Applications of Microorganisms01:30

Environmental Applications of Microorganisms

533
Microorganisms play a pivotal role in maintaining ecosystem balance by recycling essential elements such as carbon, nitrogen, and phosphorus, as well as supporting processes like bioremediation, wastewater treatment, and biofuel production.Microbes in Elemental CyclesIn the carbon cycle, microorganisms decompose organic matter, releasing carbon dioxide via aerobic respiration. This carbon dioxide is subsequently used by photosynthetic organisms to synthesize organic compounds, closing the...
533

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing pharmaceutical hazard assessment with machine learning mobility models.

Environmental science. Processes & impacts·2026
Same author

Behaviour change intervention for inhaler disposal, Spain.

Bulletin of the World Health Organization·2026
Same author

Ready-to-use 3D bioprinted scaffolds from natural materials loaded with patient's PRGF for personalized skin regeneration.

iScience·2026
Same author

Engineering early immune resilience in islet transplantation.

Trends in pharmacological sciences·2026
Same author

State-of-the-Art and Next Generation Intra-Articular Implantable Biosensors for Osteoarthritis: From Analytical Limits to Operational Stability.

Biosensors·2026
Same author

Environmentally Safe and Just Pharmacy: A Framework and Action Plan for Operating within the Earth System Boundary for Novel Entities.

Environmental science & technology·2026

Related Experiment Video

Updated: Nov 2, 2025

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
05:46

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation

Published on: August 1, 2018

13.3K

Environmental contamination by pet pharmaceuticals: A hidden problem.

Saioa Domingo-Echaburu1, Unax Lertxundi2, Alistair B A Boxall3

  • 1Pharmacy Service, Alto Deba Integrated Healthcare Organization, Arrasate, Gipuzkoa, Spain.

The Science of the Total Environment
|June 17, 2021
PubMed
Summary

Environmental risks of companion animal drugs are underestimated. Current regulations lack ecotoxicological data requirements, unlike for food-producing animals, necessitating a One Health approach for pet medications.

Keywords:
Drug pollutionEnvironmental risksExotoxicological effectsPet

More Related Videos

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.1K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.9K

Related Experiment Videos

Last Updated: Nov 2, 2025

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
05:46

Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation

Published on: August 1, 2018

13.3K
Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.1K
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.9K

Area of Science:

  • Veterinary Pharmacology
  • Environmental Risk Assessment
  • One Health Initiative

Background:

  • European Medicines Agency (EMA) does not require environmental fate, behavior, or effect data for companion animal pharmaceuticals.
  • This contrasts with stringent ecotoxicological data requirements for veterinary drugs used in food-producing animals.
  • Growing concerns exist regarding environmental impacts of antiparasitic drugs used in companion animals.

Purpose of the Study:

  • To highlight the lack of environmental risk assessment for companion animal drugs.
  • To advocate for the inclusion of environmental considerations in the benefit-risk assessment of veterinary medicines for pets.
  • To emphasize the importance of a One Health approach in veterinary drug regulation.

Main Methods:

  • Review of current European Medicines Agency (EMA) regulatory requirements for veterinary drugs.
  • Comparison of regulatory approaches for companion animal versus food-producing animal pharmaceuticals.
  • Analysis of emerging concerns regarding environmental impacts of pet medications.

Main Results:

  • Current regulations for companion animal drugs do not mandate environmental risk assessment.
  • Ecotoxicological data is a critical component for marketing authorization of drugs in food-producing animals.
  • The increasing population of companion animals suggests potential underestimation of environmental risks from their medications.

Conclusions:

  • Environmental risks associated with companion animal pharmaceuticals are likely underrated.
  • Regulatory frameworks should be updated to include environmental assessments for all veterinary drugs, aligning with One Health principles.
  • Proactive assessment of environmental impacts is crucial given the rise in pet ownership and medication use.